AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Ultragenyx Pharmaceutical Inc.

$16.10 -$7.50 (-31.78%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$16.78
Day Range
$15.92$16.93
Year Range
$12.73$39.89
Market Cap
1.59B
AVG Volume
3.79M
Trailing/Forward PE
-2.76/-
PEG ratio
0.15
Dividend Yield
-
Next Earnings Date
2026-11-03
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0200M400M600M800M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RARE Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q2716.93M
26 Q1669.43M
25 Q4672.72M
25 Q3630.6M
25 Q2610.16M
25 Q1590.69M
24 Q4560.23M
24 Q3522.75M
24 Q2481.3M
24 Q1442.59M
Net Income (USD) · TTM
-800M-600M-400M-200M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RARE Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-586.41M
26 Q1-609.36M
25 Q4-575.44M
25 Q3-579.83M
25 Q2-532.93M
25 Q1-549.58M
24 Q4-569.18M
24 Q3-558.99M
24 Q2-585.12M
24 Q1-613.35M
Operating Income (USD) · TTM
-600M-400M-200M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RARE Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-528.89M
26 Q1-561.78M
25 Q4-535.72M
25 Q3-544M
25 Q2-505.09M
25 Q1-513.57M
24 Q4-535.97M
24 Q3-535.74M
24 Q2-548.85M
24 Q1-580.45M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: RARE

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 3 Nov 2026.

Ultragenyx Pharmaceutical Inc.
RARE
Stockpicker

Video analysis: RARE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: RARE

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.